Feedback / Questions
Engensis (donaperminogene seltoplasmid) - Beijing Northland, Reyon Pharma, Helixmith
https://www.prweb.com/releases/helixmith_announces_first_patient_enrolled_in_phase_2_study_of_engensis_vm202_for_amyotrophic_lateral_sclerosis/prweb17786005.htm
Mar 10, 2021
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next